Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy.

Publication Year: 2024

DOI:
10.1136/jitc-2023-007329

PMCID:
PMC10862257

PMID:
38350684

Journal Information

Full Title: J Immunother Cancer

Abbreviation: J Immunother Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"sav) and alexa fluor 647 positive cells ( figure 2a ). table 2"

Code Sharing
Evidence found in paper:

"Competing interests: PK: founder and Chief Scientific Advisor, and received stock and receiving dividends, Epic Sciences. DH, JR and AB employed by PK. No potential conflicts of interests were disclosed by the other authors."

Evidence found in paper:

"Funding: This study was funded by Kite Pharma."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025